跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 642 条关于
“TA-MUC1”
全部
642
临床试验
311
药物
236
机构
4
资讯
91
去年
Daiichi Sankyo Acquires Solid Tumour ADC Gatipotuzumab from Glycotope for $132.5 Million
11个月前
Daiichi Sankyo's DS-3939 Shows Promising Early Results in Advanced Solid Tumors Phase 1/2 Trial
7个月前
NK Cell Engager Development Faces Mounting Setbacks as BeOne Medicines and Novartis Discontinue Programs
11个月前
ESMO 2025 Showcases Promising First-in-Human Data for KRAS G12C and FGFR3 Inhibitors
去年
Minerva Biotechnologies Advances MUC1*-Targeted CAR-T Therapy with 1XX Mutations for Solid Tumors
3个月前
South African Scientists Decode How Cancer Rewires MUC1 Sugar Coating to Evade the Immune System
去年
Narsoplimab Shows Significant Survival Benefit in TA-TMA Patients, BLA Resubmission Planned
8个月前
Omeros Receives FDA Approval for First-in-Class TA-TMA Therapy YARTEMLEA
8个月前
FDA Approves YARTEMLEA as First Therapy for Life-Threatening Transplant Complication TA-TMA
去年
Narsoplimab Shows Promising Real-World Outcomes in TA-TMA Patients at 2025 Tandem Meetings
第 1 页,共 10 页
上一页
下一页